<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>Aaj TV English News - Health</title>
    <link>https://english.aaj.tv/</link>
    <description>Aaj TV English</description>
    <language>en-Us</language>
    <copyright>Copyright 2026</copyright>
    <pubDate>Fri, 10 Apr 2026 02:41:45 +0500</pubDate>
    <lastBuildDate>Fri, 10 Apr 2026 02:41:45 +0500</lastBuildDate>
    <ttl>60</ttl>
    <item xmlns:default="http://purl.org/rss/1.0/modules/content/">
      <title>AstraZeneca antibody cocktail works against Omicron in study
</title>
      <link>https://english.aaj.tv/news/30273803/</link>
      <description>&lt;p&gt;AstraZeneca (AZN.L) said on Thursday a lab-study of its COVID-19 antibody cocktail, Evusheld, found that the treatment retained neutralising activity against the Omicron coronavirus variant, showing promise for wider use of the therapy.&lt;/p&gt;

&lt;p&gt;The study was conducted by independent investigators of the US Food and Drug Administration, the company said, adding that more analyses of Evusheld against Omicron are being conducted by AstraZeneca and third-parties, with data expected "very soon".&lt;/p&gt;
</description>
      <content:encoded xmlns="http://purl.org/rss/1.0/modules/content/"><![CDATA[<p>AstraZeneca (AZN.L) said on Thursday a lab-study of its COVID-19 antibody cocktail, Evusheld, found that the treatment retained neutralising activity against the Omicron coronavirus variant, showing promise for wider use of the therapy.</p>

<p>The study was conducted by independent investigators of the US Food and Drug Administration, the company said, adding that more analyses of Evusheld against Omicron are being conducted by AstraZeneca and third-parties, with data expected "very soon".</p>
]]></content:encoded>
      <category>Health</category>
      <guid>https://english.aaj.tv/news/30273803</guid>
      <pubDate>Fri, 17 Dec 2021 14:22:42 +0500</pubDate>
      <author>none@none.com (Reuters)</author>
      <media:content url="https://i.aaj.tv/large/2021/12/61bc569f3ab55.jpg" type="image/jpeg" medium="image" height="546" width="800">
        <media:thumbnail url="https://i.aaj.tv/thumbnail/2021/12/61bc569f3ab55.jpg"/>
        <media:title>Vials of AstraZeneca. 
SOURCE: Reuters
</media:title>
      </media:content>
    </item>
  </channel>
</rss>
